SLC5A2 and type 1 diabetes mellitus: Studies were performed comparing the effect of adjunctive use of SGLT-2 inhibitors and metformin in people with type 1 diabetes, the comparison being indirect [21] or direct [22], showing a consistent improvement in glycemic control and a reduction in body weight, blood pressure, and insulin TDD with the former compared to metformin [21,22].